[Clinical contribution to the treatment of various types of hemoblastosis with triethylene melamine].
D004194:Disease; D006402:Hematologic Diseases; D006413:Hematopoietic System; D014265:Triethylenemelamine / Q000627:therapeutic use*
D014265:Triethylenemelamine
HEMOPOIETIC SYSTEM/diseases; TRIETHYLENE MELAMINE/therapeutic use
Contributo clinico al trattamento di alcune emoblastosi con TEM.